Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study

Abstract Weights assigned to comorbidities in predicting mortality may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified version of the Charlson Comorbidity Index (CCI) using an Asian nationwide database (mCCI-A), enabling the pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jae Shin Choi, Myoung-Hee Kim, Yong Chul Kim, Youn-Hee Lim, Hyun Joo Bae, Dong Ki Kim, Jae Yoon Park, Junhyug Noh, Jung Pyo Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ec17b0a59502423bb117c16eb9262015
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ec17b0a59502423bb117c16eb9262015
record_format dspace
spelling oai:doaj.org-article:ec17b0a59502423bb117c16eb92620152021-12-02T18:50:49ZRecalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study10.1038/s41598-020-70624-82045-2322https://doaj.org/article/ec17b0a59502423bb117c16eb92620152020-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-70624-8https://doaj.org/toc/2045-2322Abstract Weights assigned to comorbidities in predicting mortality may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified version of the Charlson Comorbidity Index (CCI) using an Asian nationwide database (mCCI-A), enabling the precise prediction of mortality rates in this population. The main data source used in this study was the National Health Insurance Service-National Sample Cohort (NHIS-NSC) obtained from the National Health Insurance database, which includes health insurance claims filed between January 1, 2002, and December 31, 2013, in Korea. Of the 1,025,340 individuals included in the NHIS-NSC, 570,716 patients who were hospitalized at least once were analyzed in this study. In total, 399,502 patients, accounting for 70% of the cohort, were assigned to the development cohort, and the remaining patients (n = 171,214) were assigned to the validation cohort. The mCCI-A scores were calculated by summing the weights assigned to individual comorbidities according to their relative prognostic significance determined by a multivariate Cox proportional hazard model. The modified index was validated in the same cohort. The Cox proportional hazard model provided reassigned severity weights for 17 comorbidities that significantly predicted mortality. Both the CCI and mCCI-A were correlated with mortality. However, compared with the CCI, the mCCI-A showed modest but significant increases in the c statistics. According to the analyses using continuous net reclassification improvement, the mCCI-A improved the net mortality risk reclassification by 44.0% (95% confidence intervals (CI), 41.6–46.5; p < 0.001). The mCCI-A facilitates better risk stratification of mortality rates in Korean inpatients than the CCI, suggesting that the mCCI-A may be a preferable index for use in clinical practice and statistical analyses in epidemiological studies.Jae Shin ChoiMyoung-Hee KimYong Chul KimYoun-Hee LimHyun Joo BaeDong Ki KimJae Yoon ParkJunhyug NohJung Pyo LeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jae Shin Choi
Myoung-Hee Kim
Yong Chul Kim
Youn-Hee Lim
Hyun Joo Bae
Dong Ki Kim
Jae Yoon Park
Junhyug Noh
Jung Pyo Lee
Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
description Abstract Weights assigned to comorbidities in predicting mortality may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified version of the Charlson Comorbidity Index (CCI) using an Asian nationwide database (mCCI-A), enabling the precise prediction of mortality rates in this population. The main data source used in this study was the National Health Insurance Service-National Sample Cohort (NHIS-NSC) obtained from the National Health Insurance database, which includes health insurance claims filed between January 1, 2002, and December 31, 2013, in Korea. Of the 1,025,340 individuals included in the NHIS-NSC, 570,716 patients who were hospitalized at least once were analyzed in this study. In total, 399,502 patients, accounting for 70% of the cohort, were assigned to the development cohort, and the remaining patients (n = 171,214) were assigned to the validation cohort. The mCCI-A scores were calculated by summing the weights assigned to individual comorbidities according to their relative prognostic significance determined by a multivariate Cox proportional hazard model. The modified index was validated in the same cohort. The Cox proportional hazard model provided reassigned severity weights for 17 comorbidities that significantly predicted mortality. Both the CCI and mCCI-A were correlated with mortality. However, compared with the CCI, the mCCI-A showed modest but significant increases in the c statistics. According to the analyses using continuous net reclassification improvement, the mCCI-A improved the net mortality risk reclassification by 44.0% (95% confidence intervals (CI), 41.6–46.5; p < 0.001). The mCCI-A facilitates better risk stratification of mortality rates in Korean inpatients than the CCI, suggesting that the mCCI-A may be a preferable index for use in clinical practice and statistical analyses in epidemiological studies.
format article
author Jae Shin Choi
Myoung-Hee Kim
Yong Chul Kim
Youn-Hee Lim
Hyun Joo Bae
Dong Ki Kim
Jae Yoon Park
Junhyug Noh
Jung Pyo Lee
author_facet Jae Shin Choi
Myoung-Hee Kim
Yong Chul Kim
Youn-Hee Lim
Hyun Joo Bae
Dong Ki Kim
Jae Yoon Park
Junhyug Noh
Jung Pyo Lee
author_sort Jae Shin Choi
title Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
title_short Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
title_full Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
title_fullStr Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
title_full_unstemmed Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
title_sort recalibration and validation of the charlson comorbidity index in an asian population: the national health insurance service-national sample cohort study
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/ec17b0a59502423bb117c16eb9262015
work_keys_str_mv AT jaeshinchoi recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT myoungheekim recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT yongchulkim recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT younheelim recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT hyunjoobae recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT dongkikim recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT jaeyoonpark recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT junhyugnoh recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
AT jungpyolee recalibrationandvalidationofthecharlsoncomorbidityindexinanasianpopulationthenationalhealthinsuranceservicenationalsamplecohortstudy
_version_ 1718377539065348096